1. [Home](https://www.g2.com/) 2. ... 3. [AWS Marketplace Software](https://www.g2.com/categories/aws-marketplace) 4. [Propensity US: Have COPD Discussions](https://www.g2.com/products/propensity-us-have-copd/discuss) [ ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_a3bad54a18bbf1a4b1f739b5dcdd24ae/propensity-us-have-copd.png "Product Avatar Image") ](/products/propensity-us-have-copd/reviews) [ Propensity US: Have COPD ](/products/propensity-us-have-copd/reviews) 0 ratings Propensity US: Have COPD is a comprehensive dataset designed to assist healthcare professionals, researchers, and data scientists in identifying and analyzing individuals in the United States diagnosed with Chronic Obstructive Pulmonary Disease (COPD. This dataset provides detailed information on patient demographics, medical histories, treatment plans, and outcomes, enabling users to develop predictive models, conduct epidemiological studies, and enhance patient care strategies. Key Features and Functionality: - Extensive Data Coverage: Includes a wide range of variables such as age, gender, smoking history, comorbidities, medication usage, and hospitalization records, offering a holistic view of COPD patients. - High-Quality Data: Sourced from reputable healthcare databases, ensuring accuracy and reliability for research and analysis purposes. - Data Anonymization: All patient information is de-identified to comply with privacy regulations, allowing for ethical use in research and development. - Compatibility: Formatted for seamless integration with various data analysis tools and machine learning platforms, facilitating efficient data processing and model development. Primary Value and Problem Solving: Propensity US: Have COPD addresses the critical need for high-quality, comprehensive data in the study and management of COPD. By providing detailed patient information, it enables healthcare professionals to: - Enhance Predictive Modeling: Develop and refine models to predict disease progression, patient outcomes, and potential exacerbations, leading to proactive and personalized patient care. - Inform Treatment Strategies: Analyze treatment effectiveness and patient responses to various therapies, aiding in the optimization of treatment plans. - Support Epidemiological Research: Conduct large-scale studies to understand COPD prevalence, risk factors, and trends, contributing to public health initiatives and policy development. By leveraging this dataset, users can gain valuable insights into COPD, ultimately improving patient outcomes and advancing respiratory healthcare research. Show More When users leave Propensity US: Have COPD reviews, G2 also collects common questions about the day-to-day use of Propensity US: Have COPD. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion. * * * ### 0.0 Nps Score ### All Propensity US: Have COPD Discussions Search Most CommentedMost HelpfulPinned by G2Newest All DiscussionsDiscussions with CommentsPinned by G2Discussions without Comments FilterFilter Filter byExpand/Collapse Sort by Most Commented Most Helpful Pinned by G2 Newest Filter by All Discussions Discussions with Comments Pinned by G2 Discussions without Comments Sorry... There are no questions about Propensity US: Have COPD yet. ## Start a New Software Discussion Have a software question? Get answers from real users and experts [Start A Discussion](/products/propensity-us-have-copd/discussions/new) * * * ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_a3bad54a18bbf1a4b1f739b5dcdd24ae/propensity-us-have-copd.png "Product Avatar Image") ### Have you used Propensity US: Have COPD before? Answer a few questions to help the Propensity US: Have COPD community [ Yes ](javascript:void(0))[ Yes ](https://www.g2.com/authorize?form=signup&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fpropensity-us-have-copd%2Fdiscuss%3Fsmall_ask%3Dpropensity-us-have-copd) No